1. Ng, S. C., Z. Zeng, O. Niewiadomski, W. Tang, S. Bell, M. A. Kamm, P. Hu et al. . 2016. Early Course of Inflammatory Bowel Disease in a Population-Based Inception Cohort Study From 8 Countries in Asia and Australia. Gastroenterology 150 (1):86-95
2. Bopanna, S., A. N. Ananthakrishnan, S. Kedia, V. Yajnik, and V. Ahuja. 2017. Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis. The lancet. Gastroenterology & hepatology 2 (4):269-276.
3. Ungaro, R., S. Mehandru, P. B. Allen, L. Peyrin-Biroulet, and J. F. Colombel. 2017. Ulcerative colitis. Lancet 389 (10080):1756-1770.
4. Schmitt, H., J. Ulmschneider, U. Billmeier, M. Vieth, P. Scarozza, S. Sonnewald, S. Reid et al. . 2020. The TLR9 Agonist Cobitolimod Induces IL10-Producing Wound Healing Macrophages and Regulatory T Cells in Ulcerative Colitis. J Crohns Colitis 14 (4):508-524.
5. Xu, X., Y. Wang, Z. Wei, W. Wei, P. Zhao, B. Tong, Y. Xia, and Y. Dai. 2017. Madecassic acid, the contributor to the anti-colitis effect of madecassoside, enhances the shift of Th17 toward Treg cells via the PPARγ/AMPK/ACC1 pathway. Cell Death Dis 8 (3):e2723.
6. Grégoire, C., C. Lechanteur, A. Briquet, É. Baudoux, F. Baron, E. Louis, and Y. Beguin. 2017. Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases. Alimentary Pharmacology & Therapeutics 45 (2):205-221.
7. Liu, J. Y., L. J. Zhang, and M. Y. Liu. 2019. Mechanisms supporting potential use of bone marrow-derived mesenchymal stem cells in psychocardiology. American Journal of Translational Research 11 (11):6717-6738.
8. El Agha, E., R. Kramann, R. K. Schneider, X. Li, W. Seeger, B. D. Humphreys, and S. Bellusci. 2017. Mesenchymal Stem Cells in Fibrotic Disease. Cell Stem Cell 21 (2):166-177.
9. Zhou, C., X. R. Wu, H. S. Liu, X. H. Liu, G. H. Liu, X. B. Zheng, T. Hu et al. . 2020. Immunomodulatory Effect of Urine-derived Stem Cells on Inflammatory Bowel Diseases via Downregulating Th1/Th17 Immune Responses in a PGE2-dependent Manner. J Crohns Colitis 14 (5):654-668.
10. Zuo, D., X. Liu, Z. Shou, H. Fan, Q. Tang, X. Duan, D. Cao, Z. Zou, and L. Zhang. 2013. Study on the interactions between transplanted bone marrow-derived mesenchymal stem cells and regulatory Tcells for the treatment of experimental colitis. International Journal of Molecular Medicine. 32 (6):1337-1344.
11. Nan, Z., H. Fan, Q. Tang, M. Zhang, M. Xu, Q. Chen, Y. Liu, Y. Dong, H. Wu, and S. Deng. 2018. Dual expression of CXCR4 and IL-35 enhances the therapeutic effects of BMSCs on TNBS-induced colitis in rats through expansion of Tregs and suppression of Th17 cells. Biochemical and Biophysical Research Communications 499 (4):727-734.
12. Ishida, Y., Y. Agata, K. Shibahara, and T. Honjo. 1992. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. Embo j 11 (11):3887-3895.
13. Sun, C., R. Mezzadra, and T. N. Schumacher. 2018. Regulation and Function of the PD-L1 Checkpoint. Immunity 48 (3):434-452.
14. Zhang, Y., Z. Liu, M. Tian, X. Hu, L. Wang, J. Ji, and A. Liao. 2018. The altered PD-1/PD-L1 pathway delivers the 'one-two punch' effects to promote the Treg/Th17 imbalance in pre-eclampsia. Cell Mol Immunol 15 (7):710-723.
15. Davies, L. C., N. Heldring, N. Kadri, and K. Le Blanc. 2017. Mesenchymal Stromal Cell Secretion of Programmed Death‐1 Ligands Regulates T Cell Mediated Immunosuppression. Stem Cells 35 (3):766-776.
16. Chen, D., P. Tang, L. Liu, F. Wang, H. Xing, L. Sun, and Z. Jiang. 2018. Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T cell immune responses via PD-1/PD-L1 pathway. Cell Cycle 17 (7):858-867.
17. Gui, X., J. Li, A. Ueno, M. Iacucci, J. Qian, and S. Ghosh. 2018. Histopathological Features of Inflammatory Bowel Disease are Associated With Different CD4+ T Cell Subsets in Colonic Mucosal Lamina Propria. Journal of Crohn's & Colitis 12 (12):1448–1458.
18. Schardey, J., A. M. Globig, C. Janssen, M. Hofmann, P. Manegold, R. Thimme, and P. Hasselblatt. 2019. Vitamin D Inhibits Pro-Inflammatory T Cell Function in Patients With Inflammatory Bowel Disease. Journal of Crohn's & Colitis 13 (12):1546–1557.
19. Allbright, K. O., J. M. Bliley, E. Havis, D. Y. Kim, G. A. Dibernardo, D. Grybowski, M. Waldner et al. . 2018. Delivery of adipose‐derived stem cells in poloxamer hydrogel improves peripheral nerve regeneration. Muscle & Nerve 58 (2):251–260.
20. Khayambashi, P., J. Iyer, S. Pillai, A. Upadhyay, Y. Zhang, and S. D. Tran. 2021. Hydrogel Encapsulation of Mesenchymal Stem Cells and Their Derived Exosomes for Tissue Engineering. Int J Mol Sci 22 (2).
21. Lin, H., J. Sohn, H. Shen, M. T. Langhans, and R. S. Tuan. 2019. Bone marrow mesenchymal stem cells: Aging and tissue engineering applications to enhance bone healing. Biomaterials 203:96-110.
22. Zuo, D., Q. Tang, H. Fan, Z. Shou, X. Liu, D. Cao, and Z. Zou. 2015. Modulation of nuclear factor-κB-mediated pro-inflammatory response is associated with exogenous administration of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis. Molecular Medicine Reports 11 (4):2741-2748.
23. Wang, Y., Z. Shou, H. Fan, M. Xu, Q. Chen, Q. Tang, X. Liu et al. . 2019. Protective effects of oxymatrine against DSS-induced acute intestinal inflammation in mice via blocking the RhoA/ROCK signaling pathway. Bioscience Reports 39 (7):BSR20182297.
24. Chen, Q., X. Duan, M. Xu, H. Fan, Y. Dong, H. Wu, M. Zhang et al. . 2020. BMSC-EVs regulate Th17 cell differentiation in UC via H3K27me3. Molecular Immunology 118:191-200.
25. Imam, T., S. Park, M. H. Kaplan, and M. R. Olson. 2018. Effector T Helper Cell Subsets in Inflammatory Bowel Diseases. Frontiers in Immunology 9:1212.
26. Hu, P., M. Wang, H. Gao, A. Zheng, J. Li, D. Mu, and J. Tong. 2021. The Role of Helper T Cells in Psoriasis. Front Immunol 12:788940.
27. Yang, L., G. Wang, and H. Xia. 2020. Molecular mechanism for impaired suppressive function of Tregs in autoimmune diseases: A summary of cell-intrinsic and cell-extrinsic factors. J Cell Mol Med 24 (19):11056-11063.
28. Xu, M., X. Y. Duan, Q. Y. Chen, H. Fan, Z. C. Hong, S. J. Deng, Z. Nan et al. . 2019. Effect of compound sophorae decoction on dextran sodium sulfate (DSS)-induced colitis in mice by regulating Th17/Treg cell balance. Biomedicine & Pharmacotherapy 109:2396-2408.
29. Zhang, M., H. Fan, S. Tan, Q. Tang, X. Liu, D. Zuo, Y. Liao, Z. Nan, and C. Tan. 2020. The Chinese medicinal herb decoction QRZSLXF enhances anti-inflammatory effect in TNBS-induced colitis via balancing Th17/Tregs differentiation. Journal of Ethnopharmacology 251:112549.
30. Casiraghi, F., N. Azzollini, P. Cassis, B. Imberti, M. Morigi, D. Cugini, R. A. Cavinato et al. . 2008. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. The Journal of immunology 181 (6):3933-3946.
31. Dong, L., Y. Pu, L. Zhang, Q. Qi, L. Xu, W. Li, C. Wei et al. . 2018. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles promote lung adenocarcinoma growth by transferring miR-410. Cell Death Dis 9 (2):218.
32. Biswas, S., G. Mandal, S. Roy Chowdhury, S. Purohit, K. K. Payne, C. Anadon, A. Gupta et al. . 2019. Exosomes Produced by Mesenchymal Stem Cells Drive Differentiation of Myeloid Cells into Immunosuppressive M2-Polarized Macrophages in Breast Cancer. J Immunol 203 (12):3447-3460.
33. Gao, H., J. Zhang, and X. Ren. 2019. PD-L1 regulates tumorigenesis and autophagy of ovarian cancer by activating mTORC signaling. Bioscience Reports 39 (12):BSR20191041.
34. Dammeijer, F., M. van Gulijk, E. E. Mulder, M. Lukkes, L. Klaase, T. van den Bosch, M. van Nimwegen et al. . 2020. The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes. Cancer Cell 38 (5):685-700.e688.
35. Weyand, C. M., G. J. Berry, and J. J. Goronzy. 2018. The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease. J Leukoc Biol 103 (3):565-575.
36. Jin, H. T., R. Ahmed, and T. Okazaki. 2011. Role of PD-1 in regulating T-cell immunity. Current Topics in Microbiology & Immunology 350:17-37.
37. Davies, L. C., N. Heldring, N. Kadri, and K. Le Blanc. 2017. Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression. Stem Cells 35 (3):766-776.
38. Francisco, L. M., V. H. Salinas, K. E. Brown, V. K. Vanguri, G. J. Freeman, V. K. Kuchroo, and A. H. Sharpe. 2009. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. The Journal of Experimental Medicine 206 (13):3015–3029.
39. Jones, N., E. E. Vincent, J. G. Cronin, S. Panetti, M. Chambers, S. R. Holm, S. E. Owens, N. J. Francis, D. K. Finlay, and C. A. Thornton. 2019. Akt and STAT5 mediate naïve human CD4+ T-cell early metabolic response to TCR stimulation. Nat Commun 10 (1):2042.
40. Abdullah, L., L. B. Hills, E. B. Winter, and Y. H. Huang. 2021. Diverse Roles of Akt in T cells. Immunometabolism 3 (1).
41. Han, L., H. Shi, S. Ma, Y. Luo, W. Sun, S. Li, N. Zhang et al. . 2021. Agrin Promotes Non-Small Cell Lung Cancer Progression and Stimulates Regulatory T Cells via Increasing IL-6 Secretion Through PI3K/AKT Pathway. Front Oncol 11:804418.
42. Hawse, W. F., W. C. Boggess, and P. A. Morel. 2017. TCR Signal Strength Regulates Akt Substrate Specificity To Induce Alternate Murine Th and T Regulatory Cell Differentiation Programs. J Immunol 199 (2):589-597.
43. E., Sefik, Geva-Zatorsky N., Oh S., Konnikova L., Zemmour D., McGuire AM., Burzyn D. et al. . 2015. MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ regulatory T cells. Science (New York, N.Y.) 349 (6251):993-997.